VR Logo

Oxygenta Pharmaceutical: Sub: Related Party Transactions Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For The Half Year Ended 31St March 2022.


With respect to the cited subject please find the attached Disclosure of Related party transactions under Regulation 23(9) of the SEBI (LODR) Regulations 2015 for the half year ended 31st March 2022.Please take the same on record and acknowledge the receipt of the same.

Click here to view PDF